| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 168,597 | 163,405 | 181,250 | 249,579 | | Cost of Revenue | 145,938 | 134,076 | 157,388 | 221,936 | | | Gross Profit | 22,659 | 29,329 | 23,862 | 27,643 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 16,594 | 22,215 | 22,621 | 22,791 | | Non Recurring | 3,096 | (3,096) |
-
| 97,382 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 2,969 | 10,210 | 1,241 | (92,530) | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
|
-
| | Earnings Before Interest And Taxes | 2,969 | 10,210 | 1,241 | (92,530) | | Interest Expense | 5,897 | 6,128 | 5,971 | 7,197 | | Income Before Tax | (2,928) | 4,082 | (4,730) | (99,727) | | Income Tax Expense | 296 | 810 | 732 | 20,207 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (3,224) | 3,272 | (5,462) | (119,934) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (3,224) | 3,272 | (5,462) | (119,934) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($3,224) | $3,272 | ($5,462) | ($119,934) |
|
0.31% Nasdaq 
0.05%
Income Statement
